FDA Inspection
Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. – FDA Inspection, Mar 7, 2025
Record Details
This FDA Inspection record concerns Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., with an inspection on March 7, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- March 7, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 9173306d-cce2-4074-a429-0c5f2e571d00
Inspection Facts
- Inspection number
- 1265022
- FDA center
- Human Drugs
Other FDA inspections of Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 13, 2019 | Not classified | Office of Inspections and Investigations | |
| October 18, 2018 | Not classified | Office of Inspections and Investigations | |
| May 11, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 29, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
- FDA Inspection 1107819 - 2019-09-13
- FDA Inspection 1070378 - 2018-10-18
- FDA Inspection 1053977 - 2018-05-11
- FDA Inspection 990181 - 2016-07-29
- FDA Inspection 879374 - 2014-04-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.